Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors

Am J Clin Pathol. 2015 Mar;143(3):398-404. doi: 10.1309/AJCPQ55SKOCYFZHN.

Abstract

Objectives: We examined Ki-67 heterogeneity within single and between synchronous liver metastases of small intestine neuroendocrine tumors.

Methods: There were 27 patients (10 men and 17 women) with two or more liver metastases. The Ki-67 index was used to classify the tumors into World Health Organization grade 1, 2, or 3. The association between Ki-67 heterogeneity and tumor size of liver metastases was analyzed. Correlation of tumor grade with patient survival was also evaluated.

Results: Primary tumors from 20 patients were graded, including 17 grade 1 and three grade 2. A total of 188 liver metastases were resected, including 122 (65%) grade 1, 47 (25%) grade 2, and 19 (10%) grade 3. The highest tumor grade was grade 1 in 10 (37%), grade 2 in nine (33%), and grade 3 in eight (30%) patients. Patients with one or more grade 3 liver lesions had a shorter progression-free survival compared with those with grade 1/2 tumors (P < .001). A positive association was found between tumor size and Ki-67 index (P = .04), as well as between tumor size and intratumoral Ki-67 heterogeneity (P < .001).

Conclusions: Intratumoral and intertumoral Ki-67 heterogeneity is common and positively correlated with tumor size. The presence of one or more grade 3 liver lesions predicts a worse prognosis.

Keywords: Liver metastasis; Small intestine; Tumor heterogeneity; Well-differentiated neuroendocrine tumor.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / metabolism*
  • Demography
  • Disease Progression
  • Disease-Free Survival
  • Education, Medical, Continuing
  • Female
  • Humans
  • Intestinal Neoplasms / classification
  • Intestinal Neoplasms / mortality
  • Intestinal Neoplasms / pathology*
  • Intestine, Small / pathology
  • Ki-67 Antigen / metabolism*
  • Liver / pathology
  • Liver Neoplasms / classification
  • Liver Neoplasms / mortality
  • Liver Neoplasms / secondary*
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neuroendocrine Tumors / classification
  • Neuroendocrine Tumors / mortality
  • Neuroendocrine Tumors / secondary*
  • Prognosis
  • World Health Organization
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen